Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma
BACKGROUND AND PURPOSE: Currently it is difficult to predict tumor response to anti-
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
[PDF][PDF] Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao, JR Young… - researchgate.net
BACKGROUND AND PURPOSE: Currently it is difficult to predict tumor response to anti-
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
[引用][C] Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB POPE, A LAI, A TRAN… - American journal of …, 2011 - pascal-francis.inist.fr
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in
Newly Diagnosed Bevacizumab-Treated Glioblastoma CNRS Inist Pascal-Francis CNRS …
Newly Diagnosed Bevacizumab-Treated Glioblastoma CNRS Inist Pascal-Francis CNRS …
Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim… - AJNR. American …, 2011 - pubmed.ncbi.nlm.nih.gov
Background and purpose Currently it is difficult to predict tumor response to anti-angiogenic
therapy in individual patients. Our aim was to determine if ADC histogram analysis can …
therapy in individual patients. Our aim was to determine if ADC histogram analysis can …
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao, JR Young… - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Currently it is difficult to predict tumor response to anti-
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao… - … . American Journal of …, 2011 - europepmc.org
Background and purpose Currently it is difficult to predict tumor response to anti-angiogenic
therapy in individual patients. Our aim was to determine if ADC histogram analysis can …
therapy in individual patients. Our aim was to determine if ADC histogram analysis can …
[HTML][HTML] Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao… - … : American Journal of …, 2011 - ncbi.nlm.nih.gov
BACKGROUND AND PURPOSE: Currently it is difficult to predict tumor response to anti-
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
[引用][C] Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao… - American Journal of …, 2011 - cir.nii.ac.jp
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in
Newly Diagnosed Bevacizumab-Treated Glioblastoma | CiNii Research CiNii 国立情報学 …
Newly Diagnosed Bevacizumab-Treated Glioblastoma | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao, JR Young… - academia.edu
BACKGROUND AND PURPOSE: Currently it is difficult to predict tumor response to anti-
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
[PDF][PDF] Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
WB Pope, A Lai, R Mehta, HJ Kim, J Qiao, JR Young… - academia.edu
BACKGROUND AND PURPOSE: Currently it is difficult to predict tumor response to anti-
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …
angiogenic therapy in individual patients. Our aim was to determine if ADC histogram …